EVC
SONN

Eidelman Virant Capital’s Sonnet BioTherapeutics SONN Stock Holding History

Eidelman Virant Capital’s Portfolio SONN Stock Details SONN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– -$2K – 110
2017
Q3 		– Hold
0
– – – 107
2017
Q2 		– Hold
0
– – – 110
2017
Q1 		– Hold
0
– – – 98
2016
Q4 		– Hold
0
– – – 108
2016
Q3 		– Hold
0
– – – 118
2016
Q2 		– Hold
0
– – – 130
2016
Q1 		– Hold
0
– – – 125
2015
Q4 		– Hold
0
– – – 140
2015
Q3 		– Hold
0
– – – 128
2015
Q2 		– Hold
0
– – – 161
2015
Q1 		– Hold
0
– – – 171

Other funds holding SONN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Stumpf Capital Management Scottsdale, Arizona $53.8M AUM 43.02% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return